Cryopreservation of human vascular umbilical cord cells under good manufacturing practice conditions for future cell banks

[1]  George Doyle,et al.  Good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use , 2014 .

[2]  Wolfgang Henrich,et al.  Large Scale Expansion of Human Umbilical Cord Cells in a Rotating Bed System Bioreactor for Cardiovascular Tissue Engineering Applications , 2013, The open biomedical engineering journal.

[3]  T. Gries,et al.  Custom-Made Generation of Three-Dimensional Nonwovens Composed of Polyglycolide or Polylactide for the Cardiovascular Tissue Engineering , 2012 .

[4]  R. Hetzer,et al.  Cryopreservation of human vascular umbilical cord cells under good manufacturing practice conditions for future cell banks , 2012, Journal of Translational Medicine.

[5]  Frederick J Schoen,et al.  Heart valve tissue engineering: quo vadis? , 2011, Current opinion in biotechnology.

[6]  Nan Ma,et al.  Cell Origin of Human Mesenchymal Stem Cells Determines a Different Healing Performance in Cardiac Regeneration , 2011, PloS one.

[7]  Karin Tarte,et al.  Good manufacturing practices production of mesenchymal stem/stromal cells. , 2011, Human gene therapy.

[8]  F. Belardelli,et al.  Translational research on advanced therapies. , 2011, Annali dell'Istituto superiore di sanita.

[9]  Nan Ma,et al.  Laser printing of skin cells and human stem cells. , 2010, Tissue engineering. Part C, Methods.

[10]  D. Powell,et al.  Intestinal Mesenchymal Cells , 2010, Current gastroenterology reports.

[11]  J. Garcia.  Allogeneic unrelated cord blood banking worldwide: an update. , 2010, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[12]  K. Hatakeyama,et al.  Stromal cell biology--a way to understand the evolution of cardiovascular diseases. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[13]  K. Hatakeyama,et al.  Stromal Cell Biology , 2010 .

[14]  Benjamin T. Schmidt,et al.  High Harvest Yield, High Expansion, and Phenotype Stability of CD146 Mesenchymal Stromal Cells from Whole Primitive Human Umbilical Cord Tissue , 2009, Journal of biomedicine & biotechnology.

[15]  P. Rubinstein.  Cord blood banking for clinical transplantation , 2009, Bone Marrow Transplantation.

[16]  R. Sodian,et al.  Potential Cell Sources for Tissue Engineering of Heart Valves in Comparison With Human Pulmonary Valve Cells , 2009, ASAIO journal.

[17]  F. Straka,et al.  Tissue-engineered heart valves. , 2009, Physiological research.

[18]  E. Lurbe,et al.  Birth weight and characteristics of endothelial and smooth muscle cell cultures from human umbilical cord vessels , 2009, Journal of Translational Medicine.

[19]  M. Zago,et al.  Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. , 2008, Experimental hematology.

[20]  KAREN MENDELSON,et al.  Heart Valve Tissue Engineering: Concepts, Approaches, Progress, and Challenges , 2006, Annals of Biomedical Engineering.

[21]  Simon P Hoerstrup,et al.  Tissue engineered heart valves based on human cells. , 2006, Swiss medical weekly.

[22]  Roland Hetzer,et al.  Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. , 2006, The Annals of thoracic surgery.

[23]  Prof. Dr. med. Gustav Steinhoff.  [The regenerating heart -- hope for children with congenital heart defects]. , 2006, Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege.

[24]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[25]  S. Hoerstrup,et al.  Umbilical cord cells as a source of cardiovascular tissue engineering , 2006, Stem Cell Reviews.

[26]  Julie H. Campbell,et al.  Tissue-Engineered Blood Vessels: Alternative to Autologous Grafts? , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[27]  Diane Hoffman-Kim,et al.  Comparison of three myofibroblast cell sources for the tissue engineering of cardiac valves. , 2005, Tissue engineering.

[28]  Simon P Hoerstrup,et al.  Human umbilical cord cells for cardiovascular tissue engineering: a comparative study. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[29]  Simon P Hoerstrup,et al.  Human umbilical cord cells: a new cell source for cardiovascular tissue engineering. , 2002, The Annals of thoracic surgery.

[30]  Ralf Sodian,et al.  Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. , 2002, The Annals of thoracic surgery.

[31]  H. Vetter,et al.  Simultaneous isolation of endothelial and smooth muscle cells from human umbilical artery or vein and their growth response to low-density lipoproteins , 2002, In Vitro Cellular & Developmental Biology - Animal.

[32]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[33]  S. Bruder,et al.  Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro , 1997, Journal of cellular biochemistry.

[34]  G. V. van Eys,et al.  Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells , 1996, The Journal of cell biology.

[35]  F. R. Rosendaal,et al.  Thromboembolic and Bleeding Complications in Patients With Mechanical Heart Valve Prostheses , 1994, Circulation.

[36]  C. Walker,et al.  The Length of the Human Umbilical Cord , 1960 .

[37]  C. Walker,et al.  The length of the human umbilical cord: a statistical report. , 1960, British medical journal.

[38]  C. Dolea,et al.  World Health Organization , 1949, International Organization.